Purav Patel is Director at REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH). They have made 1 open-market trade across 1 company since 2022, most recently 2022-11-18.
CIK 0001818246
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $14K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVPH | 43,547 | $15K |
Shares reported on the most recent Form 4, priced at the 2022-11-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVPH | BUY | 2022-11-18 | 2022-11-21 | $4.69 | $14K | -19.0% | -20.1% | +7.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.